摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-carbonitrile-4-chloro-6-(3-methoxyphenyl)-2-(methylthio)pyrimidine | 128666-82-0

中文名称
——
中文别名
——
英文名称
5-carbonitrile-4-chloro-6-(3-methoxyphenyl)-2-(methylthio)pyrimidine
英文别名
4-chloro-6-(3-methoxyphenyl)-2-methylthiopyrimidine-5-carbonitrile;4-chloro-6-(3-methoxyphenyl)-2-thiomethylpyrimidine-5-carbonitrile;6-chloro-5-cyano-4-(3-methoxyphenyl)-2-methylthio-pyrimidine;6-chloro-5-cyano-4-(3-methoxyphenyl)-2-methylthiopyrimidine;4-Chloro-6-(3-methoxyphenyl)-2-(methylthio)pyrimidine-5-carbonitrile;4-chloro-6-(3-methoxyphenyl)-2-methylsulfanylpyrimidine-5-carbonitrile
5-carbonitrile-4-chloro-6-(3-methoxyphenyl)-2-(methylthio)pyrimidine化学式
CAS
128666-82-0
化学式
C13H10ClN3OS
mdl
——
分子量
291.761
InChiKey
NUVVEHIZUGPZHQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    140 °C(Solv: acetone (67-64-1))
  • 沸点:
    491.6±45.0 °C(Predicted)
  • 密度:
    1.39±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    84.1
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 储存条件:
    2-8°C

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Bicyclic heteroamatic compounds useful as LH agonists
    申请人:Akzo Nobel NV
    公开号:US06569863B1
    公开(公告)日:2003-05-27
    The invention relates to a bicyclic heteroaromatic derivative compound according to general formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is NR5R6, OR5, SR5 or R7; R5 and R6 are independently selected from H, (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, alkyl(1-8C)carbonyl, (6-14C)arylcarbonyl, (6-14C)aryl or (4-13C)heteroaryl, or R5 and R6 together are joined in a (2-7C)heterocloalkyl ring; R7 is (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl, R2 is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)alkylthio, (1-8C)(di)alkylamino, (1-8C)alkoxy, (2-8C)alkenyl, or (2-8C)alkynyl; R3 is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)(di)alkylamino or (1-8C)alkoxy; X is S, O or N(R4); R4 is H, (1-8C)alkyl, (1-8C)alkylcarbonyl, (6-14C)arylcarbonyl or (6-14C)aryl(1-8C)alkyl; Y is CH or N; Z is NH2 or OH; A is S, N(H), N(R9), O or a bond; R9 can be selected from the same groups as described for R2 and B is N(H), O or a bond. The compounds of the invention have LH receptor activating activity and can be used in fertility regulating therapies.
    该发明涉及一种按照通式(I)的双环杂芳衍生物化合物,或其药学上可接受的盐,其中R1为NR5R6、OR5、SR5或R7;R5和R6分别选自H、(1-8C)烷基、(2-8C)烯基、(2-8C)炔基、(3-8C)环烷基、(2-7C)杂环烷基、烷基(1-8C)羰基、(6-14C)芳基羰基、(6-14C)芳基或(4-13C)杂芳基,或者R5和R6一起连接在一个(2-7C)杂环烷基环中;R7为(3-8C)环烷基、(2-7C)杂环烷基、(6-14C)芳基或(4-13C)杂芳基,R2为(1-8C)烷基、(2-8C)烯基、(2-8C)炔基,或(6-14C)芳基或(4-13C)杂芳基,两者可选地被来自(1-8C)烷基、(1-8C)烷硫基、(1-8C)(二)烷基氨基、(1-8C)烷氧基、(2-8C)烯基或(2-8C)炔基的一个或多个取代基取代;R3为(1-8C)烷基、(2-8C)烯基、(2-8C)炔基、(3-8C)环烷基、(2-7C)杂环烷基,或(6-14C)芳基或(4-13C)杂芳基,两者可选地被来自(1-8C)烷基、(1-8C)(二)烷基氨基或(1-8C)烷氧基的一个或多个取代基取代;X为S、O或N(R4);R4为H、(1-8C)烷基、(1-8C)烷基羰基、(6-14C)芳基羰基或(6-14C)芳基(1-8C)烷基;Y为CH或N;Z为NH2或OH;A为S、N(H)、N(R9)、O或一个键;R9可从与R2描述的相同组中选择,B为N(H)、O或一个键。该发明的化合物具有LH受体激活活性,并可用于调节生育的治疗中。
  • Metalation of diazines X
    作者:N. Plé、A. Turck、K. Couture、G. Queguiner
    DOI:10.1016/s0040-4020(01)81762-2
    日期:1994.8
    An halogen migration of iodine during the metalation of pyrimidines has been highlighted and a mechanism is proposed. An unusual halogen-lithium exchange with LTMP has been observed. A new synthetic route to Leshmaniacides using metalation and cross coupling reactions is described.
    突出了嘧啶金属化过程中碘的卤素迁移,并提出了机理。已观察到与LTMP发生不寻常的卤素-锂交换。描述了一种利用金属化和交叉偶联反应合成莱斯曼尼酸的新途径。
  • [EN] BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS<br/>[FR] COMPOSES HETEROAROMATIQUES BICYCLIQUES UTILES EN TANT QU'AGONISTES DE L'HORMONE LUTEINISANTE (LH)
    申请人:AKZO NOBEL NV
    公开号:WO2000061586A1
    公开(公告)日:2000-10-19
    The invention relates to a bicyclic heteroaromatic derivative compound according to general formula (I), or a pharmaceutically acceptable salt thereof, wherein R?1 is NR5R6, OR5, SR5 or R7; R5 and R6¿ are independently selected from H, (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, alkyl(1-8C)carbonyl, (6-14C)arylcarbonyl, (6-14C)aryl or (4-13C)heteroaryl, or R?5 and R6¿ together are joined in a (2-7C)heterocycloalkyl ring; R7 is (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl, R2 is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)alkylthio, (1-8C)(di)alkylamino, (1-8C)alkoxy, (2-8C)alkenyl, or (2-8C)alkynyl; R3 is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)(di)alkylamino or (1-8C)alkoxy; X is S, O or N(R4); R4 is H, (1-8C)alkyl, (1-8C)alkylcarbonyl, (6-14C)arylcarbonyl or (6-14C)aryl(1-8C)alkyl; Y is CH or N; Z is NH¿2? or OH; A is S, N(H), N(R?9¿), O or a bond; R9 can be selected from the same groups as described for R2 and B is N(H), O or a bond. The compounds of the invention have LH receptor activating activity and can be used in fertility regulating therapies.
    本发明涉及一种具有一般式(I)的双环杂芳基衍生物化合物或其药学上可接受的盐,其中R1为NR5R6,OR5,SR5或R7;R5和R6分别选自H、(1-8C)烷基、(2-8C)烯基、(2-8C)炔基、(3-8C)环烷基、(2-7C)杂环烷基、烷基(1-8C)羰基、(6-14C)芳基羰基、(6-14C)芳基或(4-13C)杂芳基,或R5和R6在(2-7C)杂环烷基环中连接;R7为(3-8C)环烷基、(2-7C)杂环烷基、(6-14C)芳基或(4-13C)杂芳基,R2为(1-8C)烷基、(2-8C)烯基、(2-8C)炔基、或(6-14C)芳基或(4-13C)杂芳基,均可选择地取代一个或多个取代基,所述取代基选自(1-8C)烷基、(1-8C)烷基硫、(1-8C)(二)烷基胺基、(1-8C)烷氧基、(2-8C)烯基或(2-8C)炔基;R3为(1-8C)烷基、(2-8C)烯基、(2-8C)炔基、(3-8C)环烷基、(2-7C)杂环烷基、或(6-14C)芳基或(4-13C)杂芳基,均可选择地取代一个或多个取代基,所述取代基选自(1-8C)烷基、(1-8C)(二)烷基胺基或(1-8C)烷氧基;X为S、O或N(R4);R4为H、(1-8C)烷基、(1-8C)烷基羰基、(6-14C)芳基羰基或(6-14C)芳基(1-8C)烷基;Y为CH或N;Z为NH2或OH;A为S、N(H)、N(R9)、O或键;R9可以选择与R2相同的基团;B为N(H)、O或键。本发明的化合物具有LH受体激活活性,可用于调节生育的治疗中。
  • [EN] BICYCLIC HETEROAROMATIC COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROAROMATIQUE BICYCLIQUE
    申请人:AKZO NOBEL NV
    公开号:WO2002024703A1
    公开(公告)日:2002-03-28
    A bicyclic heteroaromatic compound according to general formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl; all optionally substituted with one or more substituents; R2 is (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (6-14C)aryl or (4-13C)heteroaryl; R3 is (1-8C)alkyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl; Y is CH or N; Z is NH¿2? or OH; A is S, N(H), N(R), O or a bond and B is N(H), O or a bond; X1-X2 is C=C, C(O)-NH, NH-C(O), C(O)-O, O-C(O), C=N, N=C or S or O. The compounds of the invention can be used in fertility regulation therapies.
    根据一般式(I),或其药学上可接受的盐,其中R1是(3-8C)环烷基,(2-7C)杂环烷基,(6-14C)芳基或(4-13C)杂芳基;均可选用一个或多个取代基;R2是(1-4C)烷基,(2-4C)烯基,(2-4C)炔基,(6-14C)芳基或(4-13C)杂芳基;R3是(1-8C)烷基,(3-8C)环烷基,(2-7C)杂环烷基,(6-14C)芳基或(4-13C)杂芳基;Y是CH或N;Z是NH2或OH;A是S,N(H),N(R),O或键;B是N(H),O或键;X1-X2是C=C,C(O)-NH,NH-C(O),C(O)-O,O-C(O),C=N,N=C或S或O。本发明的化合物可用于生育调节治疗。
  • Bicyclic heteroaromatic compounds useful as LH agonists
    申请人:——
    公开号:US20030212081A1
    公开(公告)日:2003-11-13
    The invention relates to a bicyclic heteroaromatic derivative compound according to general formula (II), 1 or a pharmaceutically acceptable salt thereof. The compounds of the invention have LH receptor activating activity and can be used in fertility regulating therapies.
    本发明涉及一种双环杂芳衍生物化合物,其通式为(II)1或其药学上可接受的盐。本发明的化合物具有LH受体激活活性,可用于生育调节疗法。
查看更多